ArticleFrontiers in cellular and infection microbiology2025
Immune pre-stimulation by injected yeast beta-glucan as a strategy to prevent calf diarrhea and bovine respiratory disease during the first 74 days of age.
Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Fungal β-1,3-glucans: Cell Wall Constituents That Promote Gut Health Through Innate Immune Modulation.Nutrients · 2026Review
- Preventive Immunology for Livestock and Zoonotic Infectious Diseases in the One Health Era: From Mechanistic Insights to Innovative Interventions.Veterinary sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The complexity of intestinal pathogens poses a great challenge to the prevention of infectious diarrhea in calves. Studies have shown that immune stimulants such as yeast beta-glucan can induce the innate immune system to acquire memory and improve their non-specific defense functions. This trial was conducted to evaluate the prophylactic effect of intraperitoneal injection of yeast β-glucan after birth on diarrhea in Holstein calves during the first 74 days of age. Methods: A total of 52 healthy newborn Holstein calves (body weight 39.3 ± 0.82 kg) were enrolled and randomly assigned into two groups (n = 26 in per group): 1) placebo group (CON), and 2) intraperitoneal injection with yeast β-glucan solution (0.1 g/mL, 50 mg/kg body weight) at 3 and 6 days of age (IP). The CON group received an equal volume of sterile saline at the same time. Body weight was measured monthly, and health checks and fecal consistency were evaluated daily for every calf. Jugular blood and rectal feces were collected at 7 and 30 days of age. Results: IP induced inflammation in calves, which was manifested as obvious increased levels of serum cytokines (IL-1β, IL-6, and TNF-a), immunoglobulin (IgG and IgM), and oxidative stress after 24 h, and the antimicrobial substance (defensin and secreted immunoglobulin A) in feces also significantly increased, but stimulation didn't lead to a higher level of serum diamine oxidase (DAO). The pre-stimulation had no positive effect on growth performance or feed efficiency, but reduced the frequencies of diarrhea and bovine respiratory disease, especially during 31-60 d. Furthermore, the pre-stimulation increased the levels of serum IL-6, fecal defensin and secreted immunoglobulin A, while decreased the levels of serum DAO and malonaldehyde at 30 d. In addition, compared with the ones in the CON group, calves in the IP group showed a better rectal bacterial structure at 30 d, with a more enrichment of beneficial bacteria such as Discussion: Our findings suggested that early stimulation with yeast β-glucan could be a promising strategy for reducing the frequencies of both diarrhea and BRD in calves.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.